Eda Cengiz, MD, MHS, FAAP
University of California, San Francisco, San Francisco, California

Eda Cengiz is Associate Professor of Pediatrics at Yale University School of Medicine and Visiting Professor of Pediatric Endocrinology at BAU School of Medicine. Most noteworthy, is her position as Director of Yale’s Insulin Pharmacokinetics and Pharmacodynamics (PK-PD) Research Study Center—the only center in the world to conduct insulin action studies in children and adolescents with type 1 diabetes.

For over a decade, Dr. Cengiz has served as a faculty member with the Yale Diabetes Research Group and has spearheaded diabetes-related clinical studies focusing on methods to accelerate insulin action, diabetes technology, and closed-loop systems. She is a member of the National Institutes of Health (NIH) Initiative to Advance Pediatric Therapeutics Diabetes Core Group and served as an elected Advisory Board Member for the International Society of Pediatric and Adolescent Diabetes (ISPAD). Dr. Cengiz collaborates with pediatric diabetologists abroad and oversees multinational projects in diabetes research and management to promote the wellbeing of children with diabetes.

Dr. Cengiz is a world-renowned scholar, who has received numerous distinguished awards from premier academic institutions, including the Yale Clinical Center for Investigation Scholar Award, the Brown University W. Alpert Medical School Dean’s Excellence in Teaching Award, and the Yale School of Medicine Mae Gailani, MD, Faculty Teaching Award. She has been the institutional Principal Investigator of various diabetes-related clinical trials and has been awarded numerous research grants to conduct investigator-initiated studies. She has developed novel evidence-based guidelines for diabetes management and has served as keynote speaker for multiple scientific conferences domestically and abroad.